Shares of Humana Inc. (NYSE:HUM - Get Free Report) gapped down before the market opened on Tuesday after Truist Financial lowered their price target on the stock from $325.00 to $305.00. The stock had previously closed at $252.86, but opened at $244.43. Truist Financial currently has a hold rating on the stock. Humana shares last traded at $235.74, with a volume of 345,626 shares changing hands.
Other analysts have also recently issued reports about the stock. Raymond James raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research note on Thursday, May 1st. Mizuho increased their price objective on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Robert W. Baird increased their price objective on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus target price of $286.81.
Check Out Our Latest Stock Report on Humana
Hedge Funds Weigh In On Humana
Institutional investors have recently bought and sold shares of the business. Transcend Capital Advisors LLC lifted its position in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after purchasing an additional 2,914 shares during the last quarter. Retirement Systems of Alabama lifted its position in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Secure Asset Management LLC bought a new position in Humana during the fourth quarter valued at $244,000. Finally, denkapparat Operations GmbH bought a new position in Humana during the fourth quarter valued at $323,000. Institutional investors own 92.38% of the company's stock.
Humana Stock Up 4.4%
The firm has a market cap of $28.65 billion, a P/E ratio of 23.86, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company's 50-day simple moving average is $262.94 and its 200 day simple moving average is $269.49.
Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same quarter in the prior year, the firm posted $7.23 earnings per share. The business's revenue for the quarter was up 8.4% on a year-over-year basis. Research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.49%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.
About Humana
(
Get Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
